首页> 美国卫生研究院文献>Turkish Journal of Ophthalmology >Comparison of Efficacy and Side Effects of Multispot Lasers and Conventional Lasers for Diabetic Retinopathy Treatment
【2h】

Comparison of Efficacy and Side Effects of Multispot Lasers and Conventional Lasers for Diabetic Retinopathy Treatment

机译:多点激光和常规激光治疗糖尿病性视网膜病的疗效和副作用的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Panretinal photocoagulation (PRP) is a standard treatment for proliferative diabetic retinopathy. Conventional laser (CL) therapy is performed in one or more sessions in single spot mode. Visual disabilities have been reported after treatment with CL, including central vision loss due to macular edema and peripheral visual field loss resulting from extensive inner retinal scarring. Multispot laser (MSL) photocoagulation has recently been introduced to clinical practice. Studies comparing PRP conducted with MSL and CL have reported that MSLs resulted in less retinal tissue damage and pain, and greater patient comfort compared to CL. The aim of this review was to compare the efficacy and side effects of MSLs and CLs for diabetic retinopathy treatment.
机译:全视网膜光凝(PRP)是增生性糖尿病视网膜病变的标准治疗方法。传统的激光(CL)治疗以单点模式在一个或多个疗程中执行。已经报道了CL治疗后的视力障碍,包括由于黄斑水肿引起的中枢视力丧失和由于广泛的内部视网膜瘢痕形成而导致的周边视野丧失。多点激光(MSL)光凝最近已被引入临床实践。与MSL和CL进行的PRP比较研究表明,与CL相比,MSL减少了视网膜组织损伤和疼痛,并提高了患者的舒适度。这篇综述的目的是比较MSLs和CLs在糖尿病性视网膜病治疗中的功效和副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号